9682
J.M. Wallace et al. / Tetrahedron 64 (2008) 9675–9684
3.1.19. 6-Chloro-1,2-dihydro-2,2-dimethylquinoxaline (33) and 7-
chloro-3,4-dihydro-3,3-dimethyl-2-quinoxalinone38 (34)
0.105 mmol) in DMF (10 mL) at 70 ꢀC under CO (6 atm, 4.5 h), as
described for 7, gave after chromatography (hexanes/EtOAc, 7:3) 40
(123 mg, 0.534 mmol, 70%) and 41 (24 mg, 0.097 mmol, 13%) as off-
Reaction of 21 (200 mg, 0.88 mmol), Pd(dba)2 (30 mg,
0.052 mmol), dppp (23 mg, 0.056 mmol), and phen (21 mg,
0.117 mmol) in DMF (10 mL) at 70 ꢀC under CO (6 atm, 5.5 h), as
described for 7, gave after chromatography (hexanes/EtOAc, 8:2) 33
(50 mg, 0.26 mmol, 29%) and 34 (84 mg, 0.40 mmol, 45%) as off-
white solids. Analytical data for 40: mp 141–142 ꢀC; 1H NMR
d 7.23
(s, 1H), 7.15 (d, J¼8.4 Hz, 1H), 6.27 (dd, J¼8.4, 2.5 Hz, 1H), 6.08 (d,
J¼2.7 Hz, 1H), 4.06 (br s, 1H), 3.76 (s, 3H), 1.80–1.30 (m, 10H); 13C
NMR
d
160.0 (þ), 157.7 (ꢁ), 137.7 (þ), 128.5 (ꢁ), 126.5 (þ), 103.4 (ꢁ),
white solids. Analytical data for 33: mp 112–114 ꢀC; 1H NMR
d
7.29
99.0 (ꢁ), 55.1 (ꢁ), 51.4 (þ), 34.7 (þ), 25.1 (þ), 20.3 (þ); IR (neat)
3243, 2927, 1612, 1582, 1466, 1308, 1257, 1102 cmꢁ1; HRMS (EI)
calcd for C14H18N2O 230.1419, found 230.1410.
(d, J¼1.7 Hz, 1H), 7.23 (d, J¼2.5 Hz, 1H), 6.96 (dd, J¼8.4, 2.2 Hz, 1H),
6.42 (d, J¼8.4 Hz, 1H), 3.78 (br s, 1H), 1.31 (s, 6H); 13C NMR
d 161.5
(ꢁ), 135.3 (þ), 132.1 (þ), 128.4 (ꢁ), 127.3 (ꢁ), 122.5 (þ), 114.5 (ꢁ),
Analytical data for 41: mp 260–263 ꢀC; 1H NMR (DMSO-d6)
50.4 (þ), 27.0 (ꢁ); IR (neat) 3249, 2970, 1600, 1485, 1455 cmꢁ1
;
d
9.93 (s, 1H), 6.59 (d, J¼8.4 Hz, 1H), 6.52 (d, J¼2.5 Hz, 1H), 6.17 (dd,
HRMS (EI) calcd for C10H11ClN2 194.0611, found 194.0619.
J¼8.6, 2.5 Hz, 1H), 5.96 (s, 1H), 3.63 (s, 3H), 1.7–1.4 (m, 10H); 13C
NMR (DMSO-d6)
d
169.5 (þ), 155.3 (þ), 134.4 (þ), 120.0 (þ), 116.6
3.1.20. 1,2-Dihydro-2,2,5-trimethylquinoxaline (35) and 3,4-
dihydro-3,3,8-trimethyl-2-quinoxalinone36 (36)
(ꢁ), 102.8 (ꢁ), 100.3 (ꢁ), 55.6 (þ), 54.9 (ꢁ), 31.4 (þ), 25.0 (þ), 19.9
(þ); IR (neat) 3368, 2929, 1672, 1518, 1259, 1015 cmꢁ1; HRMS (EI)
calcd for C14H18N2O2 246.1368, found 246.1371.
Reaction of 22 (43 mg, 0.21 mmol), Pd(dba)2 (7 mg, 0.012 mmol),
dppp (7 mg, 0.017 mmol), and phen (7 mg, 0.039 mmol) in DMF
(5 mL) at 70 ꢀC under CO (6 atm, 2 h), as described for 7, gave after
chromatography (hexanes/EtOAc, 8:2) 35 (10 mg, 0.057 mmol, 27%)
and 36 (17 mg, 0.089 mmol, 42%) as off-white solids. Analytical
3.1.24. 1,2-Dihydro-2,2-diphenyl-7-methoxyquinoxaline (42)
Reaction of 28 (96 mg, 0.28 mmol), Pd(dba)2 (10 mg,
0.017 mmol), dppp (7 mg, 0.017 mmol), and phen (7 mg,
0.039 mmol) in DMF (4 mL) at 70 ꢀC under CO (6 atm, 18 h), as
described for 7, gave after chromatography (hexanes/EtOAc, 8:2) 42
(60 mg, 0.19 mmol, 69%) as a tan solid. Mp 164–166 ꢀC; 1H NMR
data for 35: mp 79–81 ꢀC; 1H NMR
d
7.29 (s, 1H), 6.91 (t, J¼7.7 Hz,
1H), 6.58 (d, J¼7.7 Hz,1H), 6.35 (d, J¼7.7 Hz,1H), 3.65 (br s,1H), 2.41
(s, 3H), 1.31 (s, 6H); 13C NMR (150 MHz)
d
158.8 (ꢁ), 136.5 (þ), 135.6
(þ), 129.8 (þ), 128.1 (ꢁ), 119.9 (ꢁ), 111.6 (ꢁ), 49.5 (þ), 26.7 (ꢁ), 17.2
(ꢁ); IR (neat) 3275, 2960, 1590, 1464, 1289, 1160 cmꢁ1; HRMS (EI)
calcd for C11H14N2 (Mþ) 174.1157, found 174.1150.
d
7.59 (d, J¼2.5 Hz, 1H), 7.40–7.25 (m, 10H), 7.19 (d, J¼8.7 Hz, 1H),
6.27 (dd, J¼8.4, 2.5 Hz, 1H), 6.09 (d, J¼2.5 Hz, 1H), 4.43 (br s, 1H),
3.75 (s, 3H); 13C NMR
d
160.5 (þ), 153.3 (ꢁ), 144.1 (þ), 136.5 (þ),
Analytical data for 36: mp 140–141 ꢀC (lit.36 140 ꢀC).
129.1 (ꢁ), 128.6 (ꢁ), 127.6 (ꢁ), 127.4 (ꢁ), 124.7 (þ), 103.8 (ꢁ), 98.4
(ꢁ), 62.5 (þ), 55.2 (ꢁ); IR (neat) 3232, 2998, 2930, 1594, 1486, 1293,
1224, 1174, 1033 cmꢁ1; HRMS (EI) calcd for C21H18N2O 314.1419,
found 314.1409.
3.1.21. 1,2-Dihydro-2,2,8-trimethylquinoxaline (37) and 3,4-
dihydro-3,3,5-trimethyl-2-quinoxalinone38 (38)
Reaction of 23 (228 mg, 1.10 mmol), Pd(dba)2 (38 mg,
0.067 mmol), dppp (27 mg, 0.065 mmol), and phen (24 mg,
0.13 mmol) in DMF (3 mL) at 70 ꢀC under CO (6 atm, 14 h), as de-
scribed for 7, gave after chromatography (hexanes/EtOAc, in order
9:1, 8:2, 7:3 and 1:1) in order of elution 37 (120 mg, 0.69 mmol,
63%) and 38 (26 mg, 0.14 mmol, 12%) as off-white solids. Analytical
3.1.25. 7-Chloro-2-phenylquinoxaline40 (43) and 7-chloro-2-
phenylquinoxaline-1-N-oxide (44)
Reactionof29 (106 mg,0.39 mmol),Pd(dba)2 (13 mg, 0.023 mmol),
dppp (10 mg, 0.024 mmol), and phen (10 mg, 0.055 mmol) in
DMF (10 mL) at 70 ꢀC under CO (6 atm, 48 h), as described for 7,
gave after chromatography (hexanes/EtOAc, 9:1) 43 (23 mg,
0.096 mmol, 25%) and 44 (14 mg, 0.055 mmol, 14%) as off-white
solids. Analytical data for 43: mp 146–148 ꢀC41 (lit.42 130–132 ꢀC).
data for 37: mp 95–97 ꢀC; 1H NMR
J¼7.9 Hz, 1H), 6.93 (d, J¼7.4 Hz, 1H), 6.65 (t, J¼7.7 Hz, 1H), 3.53 (br s,
1H), 2.10 (s, 3H), 1.34 (s, 6H); 13C NMR
d
7.28 (d, J¼2.0 Hz, 1H), 7.14 (d,
d
159.7 (ꢁ), 134.5 (þ), 130.7
(þ), 129.8 (ꢁ), 125.5 (ꢁ), 120.8 (þ), 117.3 (ꢁ), 50.2 (þ), 27.3 (ꢁ), 16.0
(ꢁ); IR (neat) 2964, 1624, 1600, 1497, 1280, 1082 cmꢁ1; HRMS (EI)
calcd for C10H14N2 (Mþ) 174.1157, found 174.11150.
Analytical data for 44: mp 121–123 ꢀC; 1H NMR
d 9.32 (s, 1H),
8.22–8.18 (m, 2H), 8.16 (d, J¼2.2 Hz, 1H), 8.06 (d, J¼8.9 Hz, 1H), 7.69
(dd, J¼8.9, 2.2 Hz, 1H), 7.60–7.56 (m, 3H); 13C NMR (150 MHz)
Analytical data for 38: mp 182–184 ꢀC (lit.38 182 ꢀC).
d 152.6, 143.4, 142.7, 140.1, 136.3, 136.1, 130.6, 130.5, 130.4, 129.2,
128.5, 127.6; IR 1486, 1352, 1310, 1091, 915 cmꢁ1; HRMS (ESI) calcd
3.1.22. (3,4-Dihydro-3,3-dimethylquinoxalin-6-yl)phenyl-
methanone (39)
for C14H10ClN2O (MþHþ) 257.0576, found 257.0476.
Amixtureof24 (120 mg, 0.40 mmol), Pd(dba)2 (14 mg, 0.024 mmol),
dppp (10 mg, 0.024 mmol), and phen (9 mg, 0.048 mmol) in DMF
(5 mL) was reacted as described for 7 at 70 ꢀC under CO (6 atm,18 h).
The reaction mixture was filtered through Celite, the Celite was
washedwith EtOAc, andthe filtratewas concentratedunderreduced
pressure. After numerous attempts to purify the product by flash
chromatography, the yellow solid isolated was tentatively deter-
3.1.26. 1,2-Dihydro-2,2-dimethylpyrido[2,3-b]pyrazine (45) and
1,2-dihydro-2,2-dimethylpyrido[2,3-b]pyrazin-3-one (46)
Reaction of 30 (100 mg, 0.52 mmol), Pd(dba)2 (18 mg,
0.031 mmol), dppp (14 mg, 0.034 mmol), and phen (13 mg,
0.072 mmol) in DMF (5 mL) at 70 ꢀC under CO (6 atm, 6 h), as de-
scribed for 7, gave after chromatography (hexanes/EtOAc, 7:3) in
order of elution 45 (28 mg, 0.17 mmol, 34%) and 46 (5 mg,
0.028 mmol, 6%) as off-white solids. Analytical data for 45: mp 131–
mined to be 39 (56 mg of solid, <0.2 mmol, <52%). 1H NMR
d 7.79
(dd, J¼8.4,1.5 Hz, 2H), 7.57 (t, J¼7.4 Hz,1H), 7.46 (t, J¼7.6 Hz, 2H), 7.39
132 ꢀC; 1H NMR
(m, 2H), 4.03 (br s, 1H), 1.81 (s, 6H); 13C NMR
d
9.28 (s, 1H), 7.57 (dd, J¼4.7, 1.5 Hz, 1H), 6.85–6.70
(d, J¼1.7 Hz, 1H), 7.30 (d, J¼7.9 Hz, 1H), 7.08 (dd, J¼7.9, 1.8 Hz, 1H),
d
157.5 (ꢁ), 146.2 (þ),
7.03 (d, J¼1.7 Hz,1H), 4.08 (br s,1H),1.34 (s, 6H); 13C NMR
d
196.4 (þ),
137.5 (ꢁ), 131.9 (þ), 119.6 (ꢁ), 115.2 (ꢁ), 80.0 (þ), 27.5 (ꢁ); IR (neat)
2976, 1674, 1609, 1444, 1343, 1245 cmꢁ1; HRMS (EI, NH3) calcd for
C9H12N3 (MþHþ) 162.1031, found 162.1037.
163.0 (ꢁ), 137.6 (þ), 137.5 (þ), 136.8 (þ), 134.3 (þ), 132.2 (ꢁ), 129.9
(ꢁ), 128.1 (ꢁ), 127.1 (ꢁ), 120.8 (ꢁ), 115.0 (ꢁ), 50.5 (þ), 27.1 (ꢁ).
Analytical data for 46: mp 202–205 ꢀC; 1H NMR
d 9.24 (br s, 1H),
3.1.23. 70-Methoxy-spiro[cyclohexane-1,20(10H)quinoxaline] (40)
and 10,40-dihydro-70-methoxy-spiro[cyclohexane-
7.83 (dd, J¼4.9, 1.5 Hz, 1H), 6.94 (dd, J¼7.9, 1.5 Hz, 1H), 6.84 (dd,
J¼7.7, 4.9 Hz, 1H), 3.72 (br s, 1H), 1.45 (s, 6H); 13C NMR
d
171.0 (þ),
1,20(30H)quinoxalin]30-one (41)39
140.3 (þ), 137.9 (ꢁ), 128.5 (þ),120.2 (ꢁ), 119.1 (ꢁ), 56.0 (þ), 26.1(ꢁ);
IR (neat) 3310, 1683, 1558, 1458, 1289 cmꢁ1; HRMS (EI) calcd for
C9H11N3O 177.0902, found 177.0899.
Reaction of 27 (201 mg, 0.77 mmol), Pd(dba)2 (27 mg,
0.047 mmol), dppp (19 mg, 0.046 mmol), and phen (19 mg,